PTSD Trial, Recruiting NCT07217795 Sponsor: University of Rhode Island Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT07217795
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • This section's inclusion criteria were not publicly listed — please contact the trial site directly to find out if you qualify (confirm with trial site)

Who may not be able to join:

  • People who do not meet the basic requirements to be part of the study (confirm with trial site)
  • People who are currently receiving any mental health treatment at least one day per month
  • People who have received a type of talk therapy called Cognitive Behavioral Therapy (CBT) in the past 3 months (note: seeking this type of care after joining the study would not disqualify you)
  • People who are currently in treatment for alcohol or drug use problems — unless their only support is a self-help group like Alcoholics Anonymous
  • People who are currently in treatment specifically focused on trauma or PTSD
  • People who may need medical help to safely stop drinking alcohol, based on a specific screening score (confirm with trial site)
  • People who are currently experiencing active psychosis — meaning a loss of touch with reality — based on a specific screening score (confirm with trial site)
  • People who are currently experiencing a manic episode, based on a specific screening score (confirm with trial site)
  • People who are currently having serious thoughts of suicide, based on a specific screening score (confirm with trial site)
  • People who are legally required by a court or other authority to attend treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 401-874-2193

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Rhode Island
Registry
ClinicalTrials.gov
Start date
30 November 2025
Est. completion
1 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Posttraumatic Stress Disorder Diagnosis and Severity using the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5); Posttraumatic Stress Disorder Symptom Severity using the PTSD Checklist for DSM-5 (PCL-5); Hazardous drinking levels; Change in average weekly drinking quantity; Change in heavy drinking frequency

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov